RxDoctor Payments Data

Joseph Maratt, MD

Adult Reconstructive Orthopaedic Surgery · Carmel, INNPI 1093980179

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $277,909 of the $339,492 with a category attached, or 81.9%. Stryker accounts for 78.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $134,747, more than ten times the $10,873 reported in 2019.

$339,492in general payments, 2019–2025

Across 457 payments — averaging $742.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$267K
  • Medacta USA, Inc.$62K
  • Zimmer Biomet$8K
  • Smith+Nephew$3K
  • Johnson & Johnson$154
  • Encore Medical, LP$134
  • plus $144 from 3 others

What the payments were for

  • Consulting fees$277,90982%
  • Travel & lodging$48,32514%
  • Food & beverage$13,1444%
  • Gifts$1140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker331$266,925
Medacta USA, Inc.75$61,760
Zimmer Biomet25$7,853
Smith+Nephew19$2,522
Johnson & Johnson2$154
Encore Medical, LP1$134
Engage Uni, LLC1$114
Heraeus Medical, LLC.2$18
Pacira Therapeutics, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$337,680
Medicare patients
596
Services billed
3,291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib29$860
Amoxicillin187$375
Meloxicam214$341
Azithromycin48$128

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →